Vyleesi 1.75 MG per 0.3 ML Auto-Injector
- RxCUI
- 2176321
- RxNorm name
- Vyleesi 1.75 MG per 0.3 ML Auto-Injector
- Display name
- Vyleesi 1.75 MG per 0.3 ML Auto-Injector
- Full name
- Vyleesi 1.75 MG per 0.3 ML Auto-Injector
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vyleesi | BREMELANOTIDE | Cosette Pharmaceuticals, Inc. | f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf | 2025-11-13 | Warnings, Adverse reactions | 2176321 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8c9607a2-5b57-4a59-b159-cf196deebdd9 | vyleesi 1.75 MG in 0.3 mL Auto-Injector [PSN] · 0.3 ML bremelanotide 5.83 MG/ML Auto-Injector [Vyleesi] [SBD] · 0.3 ML Vyleesi 5.83 MG/ML Auto-Injector [SY] · Vyleesi 1.75 MG (equivalent to bremelanotide acetate 1.89 MG) per 0.3 ML Auto-Injector [SY] · Vyleesi 1.75 MG per 0.3 ML Auto-Injector [SY] | 5 | 6 | These highlights do not include all the information needed to use VYLEESI ® safely and effectively. See full prescribing information for VYLEESI VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019 | 20250110 |
| f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf | vyleesi 1.75 MG in 0.3 mL Auto-Injector [PSN] · 0.3 ML bremelanotide 5.83 MG/ML Auto-Injector [Vyleesi] [SBD] · 0.3 ML Vyleesi 5.83 MG/ML Auto-Injector [SY] · Vyleesi 1.75 MG (equivalent to bremelanotide acetate 1.89 MG) per 0.3 ML Auto-Injector [SY] · Vyleesi 1.75 MG per 0.3 ML Auto-Injector [SY] | 5 | 1 | These highlights do not include all the information needed to use VYLEESI ® safely and effectively. See full prescribing information for VYLEESI VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019 | 20251113 |